Literature DB >> 23889360

Diagnosis and complications of Cushing's disease: gender-related differences.

Marialuisa Zilio1, Mattia Barbot, Filippo Ceccato, Valentina Camozzi, Franca Bilora, Alessandra Casonato, Anna Chiara Frigo, Nora Albiger, Viviana Daidone, Linda Mazzai, Franco Mantero, Carla Scaroni.   

Abstract

OBJECTIVE: Cushing's disease (CD) presents a remarkable preponderance in female gender, with a female-to-male ratio of 3-8:1. The aim of this study was to evaluate gender-related differences in the presentation of CD, as regards: biochemical indices of hypercortisolism; sensitivity of diagnostic tests; clinical features and complications of disease.
METHODS: We retrospectively studied 84 adult patients with CD, 67 women and 17 men, evaluated at diagnosis. We compared the features of the disease between the sexes and analysed the effect of gender on CD complications, adjusted for potential confounders (age, gonadal status, BMI, urinary free cortisol values).
RESULTS: We observed no differences between males and females as regards age at diagnosis, disease duration and BMI. Men, compared with women, presented higher urinary free cortisol values (P < 0·001) and ACTH values (P < 0·05). As regards diagnostic tests, men presented a lower ACTH response to DDAVP stimulation (P < 0·05). The pituitary tumour itself was less easily visualized by pituitary MRI in males compared with females (P < 0·05). Furthermore, some complications of disease were more frequent or more severe in men, in particular hypokalaemia (P < 0·05), hypercoagulable state and osteoporosis at lumbar spine (P < 0·01), with consequent higher risk of vertebral fractures. Male gender was found to be an independent risk factor for dyslipidaemia, severity of hypertension, lumbar osteoporosis and fractures.
CONCLUSIONS: Although CD is less frequent in male patients, in this gender, it presents with more florid clinical manifestations and may imply more diagnostic difficulties.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23889360     DOI: 10.1111/cen.12299

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.

Authors:  Luis G Perez-Rivas; Marily Theodoropoulou; Francesco Ferraù; Clara Nusser; Kohei Kawaguchi; Constantine A Stratakis; Fabio Rueda Faucz; Luiz E Wildemberg; Guillaume Assié; Rudi Beschorner; Christina Dimopoulou; Michael Buchfelder; Vera Popovic; Christina M Berr; Miklós Tóth; Arif Ibrahim Ardisasmita; Jürgen Honegger; Jerôme Bertherat; Monica R Gadelha; Felix Beuschlein; Günter Stalla; Masayuki Komada; Márta Korbonits; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2015-05-05       Impact factor: 5.958

Review 2.  Glucose metabolism in Cushing's syndrome.

Authors:  Anu Sharma; Adrian Vella
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-06       Impact factor: 3.243

3.  Population Pharmacokinetics of Subcutaneous Pasireotide in Healthy Volunteers and Cushing's Disease Patients.

Authors:  Jerry Nedelman; Roland Fisch; Ke Hu; Ines Paule; Jocelyn Zhou
Journal:  Clin Pharmacokinet       Date:  2018-07       Impact factor: 6.447

4.  Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.

Authors:  Filippo Ceccato; Giuseppe Lombardi; Renzo Manara; Enzo Emanuelli; Luca Denaro; Laura Milanese; Marina Paola Gardiman; Roberta Bertorelle; Massimo Scanarini; Domenico D'Avella; Gianluca Occhi; Marco Boscaro; Vittorina Zagonel; Carla Scaroni
Journal:  J Neurooncol       Date:  2015-01-03       Impact factor: 4.130

Review 5.  Cushing Disease: Medical and Surgical Considerations.

Authors:  David P Bray; Rima S Rindler; Reem A Dawoud; Andrew B Boucher; Nelson M Oyesiku
Journal:  Otolaryngol Clin North Am       Date:  2022-03-04       Impact factor: 1.866

6.  Hormone secretion by pituitary adenomas is characterized by increased disorderliness and spikiness but more regular pulsing.

Authors:  Ferdinand Roelfsema; Alberto M Pereira; Nienke R Biermasz; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

Review 7.  Adrenal Tumors: Are Gender Aspects Relevant?

Authors:  Pier Francesco Alesina; Martin K Walz
Journal:  Visc Med       Date:  2020-01-15

Review 8.  The Interaction of Insulin and Pituitary Hormone Syndromes.

Authors:  Marie Helene Schernthaner-Reiter; Peter Wolf; Greisa Vila; Anton Luger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

9.  Gender-Specific Differences in Clinical Profile and Biochemical Parameters in Patients with Cushing's Disease: A Single Center Experience.

Authors:  Xiaoxia Liu; Xiaoming Zhu; Meifang Zeng; Yan Zhuang; Yiting Zhou; Zhaoyun Zhang; Yehong Yang; Yongfei Wang; Hongying Ye; Yiming Li
Journal:  Int J Endocrinol       Date:  2015-05-06       Impact factor: 3.257

10.  Management of thyrotoxicosis occurring after surgery for Cushing's disease: a case series.

Authors:  Shenzhong Jiang; Chengxian Yang; Ming Feng; Yong Yao; Kan Deng; Bing Xing; Lin Lu; Huijuan Zhu; Renzhi Wang; Xinjie Bao
Journal:  Gland Surg       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.